Market News AIOpen the app

BRVE stock news · Braveheart Bio

Stories about Braveheart Bio (BRVE) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for BRVE

Follow Braveheart Bio (BRVE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BRVE
Free on the App Store and Google Play, or on the web.
  1. Nov 7, 2026, 10:20 AM ET · Market

    Braveheart Bio shared new results from a year-long study of BHB-1893 for heart disease at a major conference.

    Good for BRVE

    Braveheart Bio reported that 79% of patients met a heart-flow measure after 52 weeks. This is encouraging for its drug, though more testing is needed.